ImmunityBio, Inc.
IBRX
$2.51
$0.041.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -59.16M | -85.73M | -134.56M | -134.11M | -233.39M |
| Total Depreciation and Amortization | 4.14M | 4.46M | 4.41M | 4.56M | 4.56M |
| Total Amortization of Deferred Charges | 5.01M | 6.20M | 5.83M | 5.55M | 7.12M |
| Total Other Non-Cash Items | -24.29M | -13.64M | 18.62M | 20.92M | 132.19M |
| Change in Net Operating Assets | -10.84M | -10.05M | 5.36M | -3.89M | -25.75M |
| Cash from Operations | -85.14M | -98.76M | -100.35M | -106.98M | -115.27M |
| Capital Expenditure | -2.11M | -2.79M | -724.00K | -1.26M | -7.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.95M | 67.82M | -50.77M | -34.36M | 10.20M |
| Cash from Investing | 9.83M | 65.03M | -51.49M | -35.62M | 2.25M |
| Total Debt Issued | 0.00 | 96.96M | -- | -- | 192.76M |
| Total Debt Repaid | 0.00 | -22.00K | -21.00K | -21.00K | -20.00K |
| Issuance of Common Stock | 107.73M | 15.90M | 52.45M | 14.12M | 9.36M |
| Repurchase of Common Stock | -803.00K | -299.00K | -496.00K | -3.87M | -1.56M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -96.96M | 96.96M | -3.00K | -- |
| Cash from Financing | 106.93M | 15.58M | 148.89M | 10.23M | 200.54M |
| Foreign Exchange rate Adjustments | -7.00K | 11.00K | 12.00K | -39.00K | -27.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.61M | -18.14M | -2.93M | -132.42M | 87.49M |